Troleandomycin

Troleandomycin
Clinical data
AHFS/Drugs.com Multum Consumer Information
MedlinePlus a604026
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
ECHA InfoCard 100.018.539 Edit this at Wikidata
Chemical and physical data
Formula C41H67NO15
Molar mass 813.968 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Troleandomycin (TAO for short[1]) is a macrolide antibiotic. It was sold in Italy (branded Triocetin) and Turkey (branded Tekmisin). It is no longer sold in Italy as of 2018.

The drug's mode of action is to bind to the ribosome, specifically in the tunnel through which the newly formed peptide egresses, thereby halting protein synthesis[2]. Troleandomycin is a CYP3A4 inhibitor that may cause drug interactions.

References

  1. Zeiger, Robert S.; Schatz, Michael; Sperling, William; Simon, Ronald A.; Stevenson, Donald D. (1980). "Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma". Journal of Allergy and Clinical Immunology. 66 (6): 438–446. doi:10.1016/0091-6749(80)90003-2. ISSN 0091-6749.
  2. Blaha, G.; Steitz,, T. A.; Moore, P. B.; Gurel, G. (2009). "Structures of Triacetyloleandomycin and Mycalamide A Bind to the Large Ribosomal Subunit of Haloarcula marismortui". Antimicrobial Agents and Chemotherapy. 53 (12): 5010–5014. doi:10.1128/AAC.00817-09. ISSN 0066-4804. PMC 2786347. PMID 19738021.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.